arrow
K

Kaja Kostyrko

Boehringer Ingelheim
H指数:14
被引数:1,089

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD

SOS1抑制剂BI-3406显示出类似基因敲除的在体抗肿瘤活性,并能与KRASG12D抑制剂协同作用,用于KRAS LUAD。

2025-03-120
OA
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance

共靶向SOS1通过解决内在和获得性耐药增强KRASG12C抑制剂的抗肿瘤作用

2024-08-051
OA
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
2020-03-0928
OAAI
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
2018-07-2535
OAAI